BRIDGEWATER, NJ -- (Marketwire) -- 10/24/08 -- Alpharma Inc. (NYSE: ALO) announced that
the company will release its third quarter 2008 earnings before the market
opens on Wednesday, October 29, 2008. Alpharma's management will conduct a
conference call / webcast on Wednesday, October 29, beginning at 8:30 AM
Eastern Daylight Time, solely to discuss its third quarter results and full
year outlook. The presentation which management will refer to on the call
will be available on the Company's website in the "Investor's Support"
section at www.alpharma.com.
The call will be open to all interested parties and may be accessed by
using the following information:
CONFERENCE CALL ACCESS
----------------------
Domestic Dial In: (800) 351-4892
International Dial In: (334) 323-7224
Conference Call ID: ALPHARMA
Investors can access the call in a "listen only" mode via the Internet at
http://www.streetevents.com.
In addition, for those unable to participate at the time of the call, a
rebroadcast will be available following the call from Wednesday, October
29, 2008 at 12:00 PM Eastern Daylight Time until Wednesday, November 12,
2008 Eastern Standard Time at midnight. The rebroadcast may be accessed on
the Internet at http://www.streetevents.com or by telephone using the
following information:
REBROADCAST ACCESS
------------------
Domestic Dial In: (877) 919-4059
International Dial In: (334) 323-7226
Participant Code: 47429233
About Alpharma
Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with
leadership positions in products for humans and animals. Alpharma is
presently active in more than 80 countries. Alpharma has a growing branded
pharmaceutical franchise in the U.S. pain market with its KADIAN®
(morphine sulfate extended-release) Capsules, and the FLECTOR® Patch
(diclofenac epolamine topical patch) 1.3%. Alpharma is also internationally
recognized as a leading provider of pharmaceutical products for poultry and
livestock.
Alpharma press releases are also available at our website.
www.alpharma.com.
Contact:
Jack Howarth
Vice President, Investor Relations
908-566-4153
Email Contact